Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register June 9, 2026. Document 2026-11526. Updated Nov. 10, 2026.
- What it does
The "Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act)," which became law on October 24, 2018, amended the Controlled Substances Act to expand the conditions a practitioner must meet to provide medication-assisted treatment for opioid use disorder and expand the options available for a physician to be considered a qualifying physician. The SUPPORT Act also allowed a pharmacy to deliver prescribed controlled substances to a practitioner's registered location for the purpose of maintenance or detoxification treatment to be administered under certain conditions by a practitioner. The Drug Enforcement Administration promulgated an interim final rule with request for comments in November 2020 to amend its regulations to make them consistent with the SUPPORT Act and implement its requirements. On December 29, 2022, the Restoring Hope for Mental Health and Well-Being Act of 2022 removed many of the statutory provisions of the SUPPORT Act. This final rule adopts the provisions of the interim final rule that are still applicable as final, with minor changes. In addition, this final rule implements the related provisions of the Restoring Hope for Mental Health and Well-Being Act of 2022.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
3 parts of Title 21 of the Code of Federal Regulations:
21 CFR 1300, 21 CFR 1301, 21 CFR 1306
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Drug Enforcement Administration has published 26 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- Before this
No earlier Federal Register document under regulation identifier 1117-AB55 since Jan. 1, 2025.
- What happens next and when
This final rule is effective July 9, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-11526 |
|---|---|
| Action | Final rule. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | June 9, 2026 |
| Effective date | July 9, 2026 |
| Regulation identifier (RIN) | 1117-AB55 |
| Docket | DEA-2020-0031 |
| Significant (marked in the Federal Register) | Yes |
Source: the Federal Register (public domain). The document in the Federal Register